Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer

Journal of Clinical Oncology - United States
doi 10.1200/jco.2010.34.4879
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Correction: Article on Phosphatidylinositol 3-Kinase in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Breast Cancer Stem Cells in Antiestrogen Resistance

2013English

Breast Cancer Stem Cells in Antiestrogen Resistance

2012English

Treating Cancer With Phosphatidylinositol-3-Kinase Inhibitors: Increasing Efficacy and Overcoming Resistance

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2019English

Breast Cancer Antiestrogen Resistance 3 (BCAR3) Promotes Cell Motility by Regulating Actin Cytoskeletal and Adhesion Remodeling in Invasive Breast Cancer Cells

PLoS ONE
Multidisciplinary
2013English

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Phosphatidylinositol 3-Kinase Regulatory Subunit 1 and Phosphatase and Tensin Homolog as Therapeutic Targets in Breast Cancer

Tumor Biology
MedicineCancer Research
2017English

Phosphatidylinositol-3-Kinase Pathway

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Phosphatidylinositol 3-Kinase Mutations Identified in Human Cancer Are Oncogenic

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy